Propiedad y actividad de insiders de Evolus, Inc. (EOLS): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $7.99 |
| Capitalización | $526M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | 0 | 0 | $93.2M | $109.9M | $102.6M | $146.3M | $53.9M | $62.8M | $87.0M | $53.8M |
| Inversiones a Corto | 0 | 0 | 0 | $19.9M | $5.0M | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | $72.6M | 0 | $10.7M | $9.7M | $14.7M | $22.4M | $30.5M | $47.7M | $54.7M |
| Inventario | 0 | 0 | 0 | $6.4M | $3.4M | $1.8M | $18.9M | $11.0M | $12.2M | $27.0M |
| Activos Corrientes | $211000 | $72.8M | $94.3M | $152.2M | $127.6M | $178.8M | $100.8M | $112.4M | $151.3M | $142.9M |
| Inmovilizado Material | 0 | 0 | 0 | $5.0M | $4.7M | $4.1M | $4.6M | $7.8M | $10.4M | $12.5M |
| Fondo de Comercio | $21.2M | $21.2M | $21.2M | $21.2M | $21.2M | $21.2M | $21.2M | $21.2M | $21.2M | $21.2M |
| Activos Intangibles | $56.1M | $56.1M | $56.1M | $59.6M | $55.3M | $50.6M | $48.6M | $47.1M | $48.8M | $48.0M |
| Activos Totales | $77.5M | $152.2M | $171.8M | $240.4M | $209.1M | $257.5M | $178.0M | $189.0M | $232.6M | $225.9M |
| Cuentas por Pagar | $2.9M | $445000 | $1.6M | $5.8M | $9.6M | $6.1M | $8.9M | $4.3M | $9.2M | $23.4M |
| Deuda a Corto | $59.8M | $211.3M | 0 | 0 | $93.5M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $63.3M | $212.7M | $5.3M | $24.4M | $180.2M | $57.7M | $46.5M | $48.3M | $63.0M | $75.3M |
| Deuda a Largo | 0 | 0 | $16.9M | $91.5M | $40.5M | $71.2M | $71.9M | $120.4M | $121.5M | $146.1M |
| Pasivos Totales | $84.6M | $227.8M | $87.5M | $161.0M | $282.0M | $175.6M | $159.5M | $209.7M | $227.0M | $249.0M |
| Reservas | -$66.8M | -$75.5M | -$123.0M | -$213.1M | -$376.1M | -$422.9M | -$497.3M | -$559.0M | -$609.4M | -$661.0M |
| Patrimonio Neto | -$7.1M | -$75.5M | -$123.0M | $79.5M | -$73.0M | $81.9M | $18.5M | -$20.7M | $5.5M | -$23.1M |
| Deuda Total | $59.8M | $211.3M | $16.9M | $96.5M | $138.3M | $74.7M | $74.4M | $126.5M | $130.0M | $155.0M |
| Deuda Neta | $59.8M | $211.3M | -$76.3M | -$33.3M | $30.8M | -$71.5M | $20.5M | $63.7M | $43.0M | $101.2M |
| Capital Circulante | -$63.1M | -$139.9M | $89.1M | $127.8M | -$52.6M | $121.1M | $54.3M | $64.1M | $88.4M | $67.6M |
Salud financiera
| Deuda / Patrimonio | -5.33 |
| Ratio corriente | 1.70 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -1.94 |
Rentabilidad
| Rentabilidad sobre capital | 123.11% |
| Rentabilidad sobre capital invertido | -15.27% |
| Rentabilidad sobre activos | -13.84% |
| Margen bruto | 66.25% |
| Margen operativo | -7.33% |
| Margen neto | -10.85% |
Empresas relacionadas: AUTL · CBLL · EHAB · KIDS · KMDA · NGNE · QSI
Explorar sector: Healthcare · Drug Manufacturers - Specialty & Generic
Más secciones de EOLS: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones